Deniz Yasar

Deniz Yasar

Auto-generated profile, based on publicly available information

Deniz Yasar

Department of Pediatrics, Ankara Etlik City Hospital, Ankara, Turkey

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 July 2024 in Journal of Pediatric Neurology
Verified
Journal Article
Closed access
PDF file
DYDeniz Yasar
Deniz Yasar
CICihan Inan
Cihan Inan
BABilge Akkaya
Bilge Akkaya
NCNesrin Ceylan
Nesrin Ceylan
BUBerna Uçan
Berna Uçan
NTNilden Tuygun
Nilden Tuygun
Idiopathic intracranial hypertension (IIH), a clinical disorder also known as pseudotumor cerebri, is characterized by increased intracranial pressure of unknown causes. Although it is most commonly observed in young obese women, IIH can also occur in the pediatric population; however, it is extremely rare in infants. Infants do not typically exhibit characteristic signs and symptoms of IIH, making it challenging to diagnose. Additionally, treatment modalities for this disease remain uncertain. We report an 8-month-old female child admitted to the pediatric emergency department with IIH. Our patient presented initially with fever, vomiting, and diarrhea, and then she developed inability to abduct the left eye. Papilledema was not detected in our patient. Magnetic resonance imaging and lumbar puncture contributed to diagnosis of the patient. Dexamethasone (0.5 mg/kg/d, twice a day) and acetazolamide (5 mg/kg/d) were administered; dexamethasone was stopped at the 48th hour after esotropia had resolved. The patient developed left ptosis in the first month after discharge. Acetazolamide was administered for a duration of 5 months and was discontinued once the patient's eye findings improved. With a sudden onset of neurological findings in a healthy infant with normal neuroimaging, IIH should be considered in the differential diagnosis and cerebrospinal fluid pressure should be measured. The principles of treatment for this disease are based on adult guidelines, but the efficacy of acetazolamide has also been reported in the pediatric population, like in our case.

31 December 2022 in Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi
Verified
Journal Article
Closed access
DYDeniz Yaşar
Deniz Yaşar
CGCem Geyi̇k
Cem Geyi̇k
AYAbdullah Yüksel
Abdullah Yüksel
OKOğuzhan Kayar
Oğuzhan Kayar
NFNurdan Di̇nLen Fettah
Nurdan Di̇nLen Fettah
Neonatal yoksunluk sendromu (NYS), gebelik süresince annenin maruz kaldığı bağımlılık yapan maddelerden dolayı, doğumdan kısa bir süre sonra bebekte oluşan çekilme bulgularıdır. Neonatal yoksunluk sendromu ile ilgili yurt dışı kaynaklı veriler ve klinik tecrübeleri içeren derlemeler mevcuttur ancak bu alanda ülkemizde yeterli çalışma bulunmamaktadır. Yenidoğan döneminde bulgular nonspesifik olup, anamnez ile desteklenmediği sürece ayırt edilmesi zordur. Bu makalede, hastanemiz Kadın Hastalıkları ve Doğum ünitesine başvuran madde bağımlı anneden doğan bebeğin yenidoğan ünitesindeki izlemi ile güncel literatürler eşliğinde NYS yaklaşımına dikkat çekilmek istenmiştir. Olgumuzda, eroin ve kanabinoid bağımlı anneden, takipsiz gebelikle Ballard skorlamasına göre 32 hafta ile uyumlu olarak doğan bebeğin yenidoğan ünitemizde NYS nedeniyle morfin ve antiepileptik tedavileri başlanarak yapılan takibi sunulmuştur.

9 December 2024 in Molecular Syndromology
Verified
Journal Article
Closed access
DYDeniz Yasar
Deniz Yasar
NLNaz Güleray Lafcı
Naz Güleray Lafcı
GKGülin Karacan Küçükali
Gülin Karacan Küçükali
AYAslıhan Araslı Yılmaz
Aslıhan Araslı Yılmaz
BDBeyhan Özkaya Dönmez
Beyhan Özkaya Dönmez
ŞEŞenay Savaş Erdeve
Şenay Savaş Erdeve
Introduction: Spondyloepiphyseal dysplasia tarda (SEDT) is an inherited disorder that is typically diagnosed in childhood or adolescence. It is characterized by disproportionate short stature and premature osteoarthritis, and it frequently affects males. Here, we described a novel nonsense mutation, c.406A>T; p(Lys136Ter), in TRAPPC2 (NM_001011658.4) in a Turkish patient with X-linked SEDT. Case Presentation: A 15-year-old boy, born to non-consanguineous Turkish parents, exhibited a decline in height velocity over 3 years and complained of back pain despite minimal physical activity. Growth and development were normal until adolescence, with the patient’s weight at 35 kg (SDS –3.85), height at 134 cm (SDS –5.44), and a predicted adult height of 137.6 cm. Dysmorphic facial features, microtia, synophrys, hypotelorism, and barrel chest were noted. Radiological examination revealed osteopenic bone structure, hypoplastic odontoid process, platyspondyly, scoliosis, short femoral necks, and coxa vara. Genetic analysis identified a hemizygous novel stop codon mutation (c.406A>T; pLys136Ter) in TRAPPC2, also detected as heterozygous in the patient’s mother. Conclusion: In adolescence or childhood, X-linked SEDT should be considered in cases of disproportionate short stature, short trunk, osteoarthritis, and a family history that is appropriate for X-linked inheritance. Skeletal survey should be performed to suspect SEDT, and radiological findings may support diagnosis.

9 December 2025 in Klinische Padiatrie
Verified
Journal Article
Closed access
PDF file
DYDeniz Yasar
Deniz Yasar
ASAbdullah Sezer
Abdullah Sezer
BKBahadır Konuskan
Bahadır Konuskan
DYDeniz Yuksel
Deniz Yuksel
Hereditary spastic paraplegia (HSP) is a genetic neurodegenerative disorder that can be categorized into two main types, uncomplicated and complicated, based on clinical manifestations. The disease has various inheritance patterns, including autosomal recessive (AR), autosomal dominant (AD), and X-linked forms (Hedera P et al., GeneReviews(R), Seattle (WA); 1993). It is characterized by motor neuron degeneration affecting the corticospinal tract. Complicated HSP is associated with additional symptoms such as seizures, intellectual disability, dementia, extrapyramidal disturbances, peripheral neuropathy, and muscle atrophy (Hedera P et al., GeneReviews(R), Seattle (WA); 1993). HSP exhibits genetic and clinical heterogeneity and is linked to over 80 loci or genes (Murala S et al., Neurol Sci 2021; 42: 883–894). There are 76 documented spastic gait disease-loci (SPG) ranging from SPG1 to SPG76, with over 50 corresponding genes (Damiani D et al., Int J Mol Sci 2024; 25). Despite the fact that many distinct genes have been discovered, it is now understood that they produce proteins involved in just a small number of cellular functions, such as intracellular trafficking, organelle shaping, myelination, development, metabolism (lipid and nucloside metabolism), recycling/degradation, cytoskeleton dynamics, mitochondrial functions, and signaling pathways (Elsayed LEO et al., Front Mol Biosci 2021; 8: 690899). The 5′ nucleotidase cytosolic II (NT5C2) enzyme plays a crucial role in nucleotide metabolism and maintaining purine pools in the brain and spinal cord (Dieck CL et al., Cancer Cell 2018; 34: 136–147.e136 and Camici M et al., Neurochem Int 2010; 56: 367–378). It contributes to the dephosphorylation of adenosine monophosphate and inosine monophosphate, leading to the production of adenosine which regulates neuronal transmission and has neuroprotective properties (Camici M et al., Neurochem Int 2010; 56: 367–378 and Straussberg R et al., Am J Med Genet A 2017; 173: 3109–3113). Loss-of-function (LoF) variants in NT5C2 result in HSP, while somatic gain-of-function (GoF) variants are associated with treatment-resistant leukemia (Dieck CL et al., Cancer Cell 2018; 34: 136–147.e136 and Novarino G et al., Science 2014; 343: 506–511). SPG45 was first identified in 2009 by Dursun et al. due to a homozygous truncating variant in the NT5C2 gene and is associated with AR-HSP with intellectual disability (Dursun U et al., Neurogenetics 2009; 10: 325–331). To date, seven articles have reported 25 patients with NT5C2 LoF variants from 11 different families (Straussberg R et al., Am J Med Genet A 2017; 173: 3109–3113, Novarino G et al., Science 2014; 343: 506–511, Dursun U et al., Neurogenetics 2009; 10: 325–331, Elsaid MF et al., BMC Med Genet 2017; 18: 33, Darvish H et al., NPJ Genom Med 2017; 2, Naseer MI et al., Front Genet 2020; 11: 14, Ipek R et al., Mol Syndromol 2024; 15: 297–302). In this article, we present the clinical, radiological, and genetic findings of two siblings of the Turkish origin who have SPG45 due to a novel likely pathogenic variant in the NT5C2 gene. Received: 12 March 2025 Accepted after revision: 20 November 2025 Article published online: 09 December 2025 © 2025. Thieme. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany

29 August 2026 in The Turkish Journal of Pediatrics
Verified
Journal Article
Open access
PDF file
DYDeniz Yaşar
Deniz Yaşar
MKMustafa Kılıç
Mustafa Kılıç
AKAbdulkerim Kolkiran
Abdulkerim Kolkiran
ABAyşe Kaçar Bayram
Ayşe Kaçar Bayram
ÖNÖzlem Sarıtaş Nakip
Özlem Sarıtaş Nakip
EAElif Soyak Aytekin
Elif Soyak Aytekin
Introduction. RNU4ATAC-opathy is a rare autosomal recessive disorder characterized by a wide clinical spectrum, including brain anomalies, seizures, strokes, immunodeficiency, and cardiac defects. Other manifestations include ophthalmologic, dermatologic, renal, gastrointestinal, auditory, and endocrine involvement. Here, we report the identification of pathogenic RNU4ATAC variants through whole exome sequencing in an infant presenting with microcephaly, growth failure, and immunodeficiency. Case Presentation. We describe an 11-month-old infant who had been followed since 4 months of age for growth failure and developmental delay. During follow-up, the patient experienced episodes of neurological deterioration triggered by febrile illnesses associated with SARS-CoV-2 and respiratory syncytial virus infections (RSV) at 9 and 11 months of age, respectively. Immunological evaluation showed normal immunoglobulin levels, a marked reduction in switched memory and memory B cells, impaired T-cell activation, and decreased T-cell subpopulations, suggesting combined immunodeficiency that may have contributed to increased susceptibility to viral infections. Whole exome sequencing subsequently identified compound heterozygous pathogenic variants in the RNU4ATAC gene, confirming the diagnosis of RNU4ATAC-opathy. Discussion. RNU4ATAC-opathy should be considered in cases with microcephaly, growth failure, immunodeficiency, and skeletal abnormalities. Our case shows that RNU4ATAC-opathy may present as infection-related encephalopathy, together with combined T- and B-cell dysfunction. Early immunological assessment and timely initiation of prophylactic therapy could play a key role in improving survival. Genetic and immunological evaluations are essential for accurate diagnosis, early intervention, and effective management. Further research is needed to clarify the syndrome’s impact on immune function and guide targeted therapies.

17 February 2025 in Journal of Pediatric Endocrinology and Metabolism
Verified
Journal Article
Closed access
DYDeniz Yasar
Deniz Yasar
ASAbdullah Sezer
Abdullah Sezer
CACaner Aytekin
Caner Aytekin
GKGülin Karacan Küçükali
Gülin Karacan Küçükali
BDBeyhan Özkaya Dönmez
Beyhan Özkaya Dönmez
ŞEŞenay Savaş Erdeve
Şenay Savaş Erdeve
Objectives: DNA ligase IV (LIG4) deficiency is a rare autosomal recessive disorder associated with impaired DNA damage-response mechanisms. LIG4 deficiency exhibits a broad clinical spectrum, including microcephaly, facial abnormalities, sensitivity to ionizing radiation, ranging from severe combined immunodeficiency to normal immune function, progressive bone marrow failure, and predisposition to malignancy. Case Presentation: We report an 18-year-old girl of consanguineous Turkish parents, first evaluated at 13 years old for growth retardation and short stature. She was born preterm at 32 weeks with dysmorphic facial features, lissencephaly, intellectual disability, and without immunodeficiency. Although diagnosed with growth hormone deficiency, she did not receive appropriate hormone therapy due to special circumstances. At the age of 15, she presented with primary amenorrhea. Further evaluation revealed hypergonadotropic hypogonadism due to gonadal failure. Genetic analysis revealed a homozygous c.2440C>T (p.Arg814Ter) mutation in the LIG4 gene. Following genetic counseling, her parents opted for prenatal diagnosis in a subsequent pregnancy, resulting in the birth of another child with the same condition. Conclusions: LIG4 syndrome should be considered in the differential diagnosis of cases with growth retardation, microcephaly, and gonadal failure. In the literature, there are limited cases reported with gonadal failure in LIG4 syndrome. Here, we emphasize this aspect to highlight its significance.